This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/company/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02955/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02955/identifier/kegg-compound/
n14http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB02955/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02955/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02955/identifier/drugbank/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02955/identifier/chebi/

Statements

Subject Item
n2:DB02955
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n14:DB02955 n16:DB02955
dcterms:title
Ricinoleic Acid
adms:identifier
n7:5312852 n8:46506721 n9:C08365 n10:RCL n11:28592 n12:DB02955
n3:packager
n5:271B4185-363D-11E5-9242-09173F13E4C5 n5:271B4187-363D-11E5-9242-09173F13E4C5 n5:271B4188-363D-11E5-9242-09173F13E4C5 n5:271B4186-363D-11E5-9242-09173F13E4C5 n5:271B4189-363D-11E5-9242-09173F13E4C5 n5:271B418A-363D-11E5-9242-09173F13E4C5
n3:synthesisReference
Bernd Fabry, Robert Piorr, Frank Clasen, Horst Ritterbex, Hans Bornmann, "Process for the preparation of reaction products of epoxidized ricinoleic acid glycerides with sulfur trioxide." U.S. Patent US4981617, issued December, 1966.
n3:IUPAC-Name
n4:271B418F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4195-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4194-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4191-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4192-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4193-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B418D-363D-11E5-9242-09173F13E4C5 n4:271B41A5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B418B-363D-11E5-9242-09173F13E4C5 n4:271B418E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B418C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B419B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B419C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4196-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4197-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4199-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4198-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B419A-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
141-22-0
n3:Bioavailability
n4:271B41A1-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B41A7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B41A3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B41A4-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B41A6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B41A0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B419F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B41A2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4190-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B419D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B419E-363D-11E5-9242-09173F13E4C5